Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4.3Revenue $M42.5Net Margin (%)--Altman Z-Score--
Enterprise Value $M4.3EPS $1.4Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales0.15-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SKBI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

SKBI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SKBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GREGORY JOHN M10% Owner 2015-02-02Buy38,730$4.21-88.36view
GREGORY JOHN M10% Owner 2014-12-23Buy70,800$4.28-88.55view
GREGORY JOHN M10% Owner 2014-12-10Buy103,016$4.56-89.25view

Press Releases about SKBI :

Quarterly/Annual Reports about SKBI:

    News about SKBI:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    SKYSTAR BIO-PHARMACEUTICAL CO Financials Dec 24 2015
    Skystar Bio-Pharmaceutical Company Update Dec 22 2015
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Dec 18 2015
    Skystar Bio-Pharmaceutical Company Announces Delisting From NASDAQ Dec 18 2015
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Nov 20 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Notification Letter Nov 19 2015
    Skystar Bio-Pharmaceutical Company Request to Stay Nasdaq Trading Suspension Granted Nov 06 2015
    Skystar Bio-Pharmaceutical Company Receives Approval for T-Factor Animal Supplement Patent From... Oct 27 2015
    Skystar Bio-Pharmaceutical Company Receives Approval for T-Factor Animal Supplement Patent From... Oct 27 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Notification Letter Oct 23 2015
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Oct 23 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Notification Letter Oct 23 2015
    Skystar Bio-Pharmaceutical Company Provides Investor Update Regarding Delay in Filing Form 10-K Oct 02 2015
    Skystar Bio-Pharmaceutical Company Provides Investor Update Regarding Delay in Filing Form 10-K Oct 02 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Non-Compliance Letter Due to Delay in... Aug 25 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Non-Compliance Letter Due to Delay in... Aug 25 2015
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Aug 25 2015
    Skystar Bio-Pharmaceutical Company Announces Submission of Plan of Compliance With Nasdaq Jun 15 2015
    Skystar Bio-Pharmaceutical Company Announces Submission of Plan of Compliance With Nasdaq Jun 15 2015
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Non-Compliance Letter Due to Delay in... May 22 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK